Ingalls Cancer Research Center

Harvey, Illinois 60426

0 studies enrolling now · 14 studies all time

What they study most

Cancer, Carcinoma, Pancreatic Ductal, Chemotherapy Side Effects, Chronic Lymphocytic Leukemia, Colorectal Cancer, Fatigue, Gastroesophageal Cancer, Head and Neck Cancer, Melanoma, Metastatic Colorectal Cancer, Multiple Myeloma, Neuroendocrine Cancer

Studies at this site

Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers — Completed
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal) — Completed
Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer — Completed
Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study — Completed
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO) — Stopped early
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry — Completed
Everolimus Versus Placebo in Head and Neck Cancer — Stopped early
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) — Completed
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents — Stopped early
FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer — Completed
Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer — Completed
Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors. — Completed